Skip to main content

FDA advisory committee to discuss future of Covid boosters

An FDA advisory committee will discuss Covid-19 boosters for the coming months, and what factors would make it necessary to update the shots to target specific variants.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.